Search Results - "Guo, Yizhen"

Refine Results
  1. 1

    Recent developments of human monocarboxylate transporter (hMCT) inhibitors as anticancer agents by Wu, Puhua, Zhou, Yan, Guo, Yizhen, Zhang, Shao-Lin, Tam, Kin Yip

    Published in Drug discovery today (01-03-2021)
    “…•Recent development of hMCTs inhibitors targeting cancer metabolism is described.•Structural information of hMCT1 and hMCT4 is summarized for rational…”
    Get full text
    Journal Article
  2. 2

    One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy by Hong, Chao, Liang, Jianming, Xia, Jiaxuan, Zhu, Ying, Guo, Yizhen, Wang, Anni, Lu, Chunyi, Ren, Hongwei, Chen, Chen, Li, Shiyi, Wang, Dan, Zhan, Huaxing, Wang, Jianxin

    Published in Nano-micro letters (16-06-2020)
    “…Highlights A ginsenoside Rh2-based multifunctional liposome system (Rh2-lipo) was innovatively developed. Rh2-lipo not only innovatively challenges the…”
    Get full text
    Journal Article
  3. 3

    In Vitro/In Vivo Metabolism of Ginsenoside Rg5 in Rat Using Ultra-Performance Liquid Chromatography/Quadrupole-Time-of-Flight Mass Spectrometry by Hong, Chao, Yang, Ping, Li, Shuping, Guo, Yizhen, Wang, Dan, Wang, Jianxin

    Published in Molecules (Basel, Switzerland) (22-08-2018)
    “…: Ginsenoside Rg5 has been proved to have a wide range of pharmacological activities. However, the in vitro and in vivo metabolism pathways of ginsenosides are…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Carbon Nanotubes Grown Using Solid Polymer Chemical Vapor Deposition in a Fluidized Bed Reactor with Iron(III) Nitrate, Iron(III) Chloride and Nickel(II) Chloride Catalysts by Wang, Chuhsuan, Chang, Jingshiun, Amatosa, Teodoro, Guo, Yizhen, Lin, Fujen, Yen, Yeewen

    Published in Inventions (Basel) (01-03-2018)
    “…In this study, multi-walled carbon nanotubes (MW-CNT) were successfully synthesized using a chemical vapor deposition-fluidized bed (CVD-FB), with 10% hydrogen…”
    Get full text
    Journal Article
  8. 8

    Targeting glucose metabolism to develop anticancer treatments and therapeutic patents by Zhou, Yan, Guo, Yizhen, Tam, Kin Yip

    Published in Expert opinion on therapeutic patents (03-04-2022)
    “…One of the most distinctive hallmarks of cancer cells is increased glucose consumption for aerobic glycolysis, which is called the Warburg effect. In recent…”
    Get more information
    Journal Article
  9. 9

    Navigating legal responsibilities in politically connected firms: Insights into the influence of directors' and officers' insurance on litigation risk by Zhang, Xiaojuan, Guo, Yizhen, Chi, Tiancheng

    Published in Managerial and decision economics (19-09-2024)
    “…Abstract This study aims to investigate how directors' and officers' (D&O) liability insurance, legal responsibilities, and firm political connections…”
    Get full text
    Journal Article
  10. 10

    Harnessing traditional Chinese medicine polysaccharides for combatting COVID-19 by Xiao, Zhiyong, Guo, Yizhen, Li, Jingxuan, Jiang, Xuyong, Wu, Fushan, Wang, Ying, Zhang, Yongxiang, Zhou, Wenxia

    Published in Carbohydrate polymers (15-12-2024)
    “…With the global spread of COVID-19 posing ongoing challenges to public health systems, there is an ever-increasing demand for effective therapeutics that can…”
    Get full text
    Journal Article
  11. 11

    Advanced nonhomogeneous wind field simulation for offshore Turbines via enhanced A-R scheme by Wu, Yongxin, Guo, Yizhen, Cheng, Haifeng, Chen, Yinying, Li, Bing, Lai, Ying

    Published in Applied energy (01-01-2025)
    “…The precise and efficient simulation of the spatial variable wind field is the underpinning of the dynamic response analysis of the wind turbine structure. The…”
    Get full text
    Journal Article
  12. 12

    Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer by Hong, Chao, Wang, Dan, Liang, Jianming, Guo, Yizhen, Zhu, Ying, Xia, Jiaxuan, Qin, Jing, Zhan, Huaxing, Wang, Jianxin

    Published in Theranostics (01-01-2019)
    “…The clinical treatment of gastric cancer (GC) is hampered by the development of anticancer drug resistance and the unfavorable pharmacokinetics, off-target…”
    Get full text
    Journal Article
  13. 13

    Combined inhibition of pyruvate dehydrogenase kinase 1 and hexokinase 2 induces apoptsis in non-small cell lung cancer cell models by Guo, Yizhen, Lu, Xianchen, Zhou, Yan, Chen, Wen-Hua, Tam, Kin Yip

    Published in Experimental cell research (15-12-2023)
    “…Many cancer cells exhibit enhanced glycolysis, which is seen as one of the hallmark metabolic alterations, known as Warburg effect. Substantial evidence shows…”
    Get full text
    Journal Article
  14. 14

    Impact of molecular weight and gastrointestinal digestion on the immunomodulatory effects of Lycium barbarum polysaccharides by Guo, Yizhen, Zhao, Xueru, Xiao, Shiqi, Lin, Yanling, Xiao, Zhiyong, Zhou, Wenxia, Zhang, Yongxiang

    “…In traditional Chinese medicine, Lycium barbarum is of rich medicinal value, and its polysaccharides are particularly interesting due to their significant…”
    Get full text
    Journal Article
  15. 15

    Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing by Zhou, Yan, Guo, Yizhen, Ran, Maoxin, Shan, Wenying, Granchi, Carlotta, Giovannetti, Elisa, Minutolo, Filippo, Peters, Godefridus J., Tam, Kin Yip

    Published in Cancer letters (28-11-2023)
    “…Lung adenocarcinoma (LUAD) is one of the most prevalent and aggressive types of lung cancer. Metabolic reprogramming plays a critical role in the development…”
    Get full text
    Journal Article
  16. 16

    Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models by Guo, Yizhen, Zhou, Yan, Wu, Puhua, Ran, Maoxin, Xu, Ngai, Shan, Wenying, Sha, Ou, Tam, Kin Yip

    Published in Chemico-biological interactions (01-06-2023)
    “…Pyruvate dehydrogenase kinase 1 (PDK1) is an important metabolic enzyme which is often overexpressed in many types of cancers, including non-small-cell lung…”
    Get full text
    Journal Article
  17. 17

    Cytosolic malic enzyme and glucose-6-phosphate dehydrogenase modulate redox balance in NSCLC with acquired drug resistance by Ran, Maoxin, Zhou, Yan, Guo, Yizhen, Huang, Ding, Zhang, Shao-Lin, Tam, Kin Yip

    Published in The FEBS journal (01-10-2023)
    “…Lung cancer cells often show elevated levels of reactive oxygen species (ROS) and nicotinamide adenine dinucleotide phosphate (NADPH). However, the connections…”
    Get full text
    Journal Article
  18. 18

    A Mitochondria-Targeted Phenylbutyric Acid Prodrug Confers Drastically Improved Anticancer Activities by Huang, Ding, Liu, Qingwang, Zhang, Maojie, Guo, Yizhen, Cui, Zhiying, Li, Tao, Luo, Dong, Xu, Biao, Huang, Chao, Guo, Jian, Tam, Kin Yip, Zhang, Min, Zhang, Shao-Lin, He, Yun

    Published in Journal of medicinal chemistry (28-07-2022)
    “…Phenylbutyric acid (PBA) has been reported as a dual inhibitor of pyruvate dehydrogenase kinases (PDKs) and histone deacetylases (HDACs), exhibiting anticancer…”
    Get full text
    Journal Article
  19. 19

    Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis by Zhou, Yan, Huang, Shiqi, Guo, Yizhen, Ran, Maoxin, Shan, Wenying, Chen, Wen‐Hua, Tam, Kin Yip

    Published in Phytotherapy research (01-12-2023)
    “…Upon prolonged use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in non‐small‐cell lung cancer (NSCLC), acquired drug resistance…”
    Get full text
    Journal Article
  20. 20